JP2012508256A - 抗炎症性化合物およびその組成物 - Google Patents

抗炎症性化合物およびその組成物 Download PDF

Info

Publication number
JP2012508256A
JP2012508256A JP2011535734A JP2011535734A JP2012508256A JP 2012508256 A JP2012508256 A JP 2012508256A JP 2011535734 A JP2011535734 A JP 2011535734A JP 2011535734 A JP2011535734 A JP 2011535734A JP 2012508256 A JP2012508256 A JP 2012508256A
Authority
JP
Japan
Prior art keywords
formula
compound
pharmaceutically acceptable
inflammation
denture adhesive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011535734A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012508256A5 (US06780888-20040824-C00057.png
Inventor
ショーン、エム．ウェテラー
ヤン、ジンジュン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
GlaxoSmithKline LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline LLC filed Critical GlaxoSmithKline LLC
Publication of JP2012508256A publication Critical patent/JP2012508256A/ja
Publication of JP2012508256A5 publication Critical patent/JP2012508256A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dental Preparations (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2011535734A 2008-11-10 2009-11-10 抗炎症性化合物およびその組成物 Pending JP2012508256A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11290008P 2008-11-10 2008-11-10
US61/112,900 2008-11-10
PCT/US2009/063773 WO2010054344A1 (en) 2008-11-10 2009-11-10 Anti-inflammatory compounds and compositions thereof

Publications (2)

Publication Number Publication Date
JP2012508256A true JP2012508256A (ja) 2012-04-05
JP2012508256A5 JP2012508256A5 (US06780888-20040824-C00057.png) 2012-12-27

Family

ID=42153302

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011535734A Pending JP2012508256A (ja) 2008-11-10 2009-11-10 抗炎症性化合物およびその組成物

Country Status (7)

Country Link
US (1) US20110207817A1 (US06780888-20040824-C00057.png)
EP (1) EP2361087A4 (US06780888-20040824-C00057.png)
JP (1) JP2012508256A (US06780888-20040824-C00057.png)
CN (1) CN102271675A (US06780888-20040824-C00057.png)
AR (1) AR074309A1 (US06780888-20040824-C00057.png)
TW (1) TW201029651A (US06780888-20040824-C00057.png)
WO (1) WO2010054344A1 (US06780888-20040824-C00057.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11235013B2 (en) * 2018-09-04 2022-02-01 Babak Ghalili Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods
US11344495B2 (en) 2018-09-04 2022-05-31 Babak Ghalili Veterinary cannabinoid, menthol and anesthetic compositions and methods
US10813889B2 (en) * 2018-09-04 2020-10-27 Babak Ghalili Cannabinoid and menthol compositions and methods
US11147775B2 (en) * 2018-09-04 2021-10-19 Babak Ghalili Cannabinoid and menthol gel compositions, patches and methods
US10813963B2 (en) 2018-09-04 2020-10-27 Babak Ghalili Veterinary cannabinoid and menthol compositions and methods
US11185526B2 (en) * 2018-09-04 2021-11-30 Babak Ghalili Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods
US11229610B2 (en) 2018-09-04 2022-01-25 Babak Ghalili Cannabinoid and menthol gel compositions, patches and methods
US11376227B2 (en) 2018-09-04 2022-07-05 Babak Ghalili Cannabinoid and menthol gum and lozenge compositions and methods
CN113376386A (zh) * 2020-03-09 2021-09-10 中国科学院广州生物医药与健康研究院 一种病毒性肺炎的标志物及其应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003081799A (ja) * 2001-06-27 2003-03-19 Lion Corp 練歯磨剤組成物
WO2008008494A2 (en) * 2006-07-13 2008-01-17 Accentia Biopharmaceuticals, Inc. Methods and compositions for treating mucosal inflammation
JP2008253303A (ja) * 2007-03-30 2008-10-23 Kobayashi Pharmaceut Co Ltd 義歯安定剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1156689A1 (ru) * 1982-09-27 1985-05-23 Харьковский Научно-Исследовательский Химико-Фармацевтический Институт Противовоспалительное средство "гипозоль
US4672076A (en) * 1984-04-27 1987-06-09 Warner-Lambert Company Non-steroidal anti-inflammatory compounds and compositions thereof
US6375963B1 (en) * 1999-06-16 2002-04-23 Michael A. Repka Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof
FR2797763B1 (fr) * 1999-08-25 2002-06-21 Gilles Brun Dentifrice liquide sans rincage et sans abrasif, et dispositif de pulverisation
US20040028930A1 (en) * 2000-10-10 2004-02-12 Eddie Wong Film extruded denture adhesive liner
US20060127505A1 (en) * 2002-01-16 2006-06-15 David Haines Anti-inflammatory formulations
US20060134025A1 (en) * 2004-12-17 2006-06-22 Colgate-Palmolive Company Oral compositions containing extracts of Rosmarinus and related methods
JP2007161681A (ja) * 2005-12-16 2007-06-28 Mitsui Chemicals Inc しわ防止および皮膚状態改善剤

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003081799A (ja) * 2001-06-27 2003-03-19 Lion Corp 練歯磨剤組成物
WO2008008494A2 (en) * 2006-07-13 2008-01-17 Accentia Biopharmaceuticals, Inc. Methods and compositions for treating mucosal inflammation
JP2008253303A (ja) * 2007-03-30 2008-10-23 Kobayashi Pharmaceut Co Ltd 義歯安定剤

Also Published As

Publication number Publication date
EP2361087A4 (en) 2012-04-25
US20110207817A1 (en) 2011-08-25
AR074309A1 (es) 2011-01-05
WO2010054344A1 (en) 2010-05-14
EP2361087A1 (en) 2011-08-31
CN102271675A (zh) 2011-12-07
TW201029651A (en) 2010-08-16

Similar Documents

Publication Publication Date Title
JP2012508256A (ja) 抗炎症性化合物およびその組成物
US7943169B2 (en) Absorbable solid compositions for topical treatment of oral mucosal disorders
RU2450819C2 (ru) Травяные композиции для лечения заболеваний полости рта
JPH05503280A (ja) 歯とその支持組織の症状の治療のための局所用製剤
US8114448B2 (en) Herbal dental care composition, method of manufacturing the same and use thereof
RU2571063C2 (ru) Полисахарид семени тамаринда для применения в лечении микробных инфекций
WO2009106963A2 (en) Dental composition for preventing and treating stomatitis and mouth ulcers
AU2011257388B2 (en) Tamarind seed polysaccharide for use in the treatment of inflammatory diseases
WO2006109344A2 (en) Composition to be used for the treatment of parodontal pathologies
CN108324739B (zh) 一种药物组合物及其应用、以及口腔清洁护理产品、口腔用保健品及药品
Ali et al. Propolis buccal paste in treatment of aphthous ulceration: formulation and clinical evaluation
CA2529441C (en) Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas
JPS62148426A (ja) 歯周病治療剤
CN108299372B (zh) 一种用于防治牙龈炎的药物及其制备方法
US20230017654A1 (en) Anti-inflammatory liquid composition for covering oral mucosa and pharmaceutical composition for prevention and/or treatment of stomatitis using same
JPH0761933B2 (ja) 口腔用組成物
RU2754828C1 (ru) Стоматологический гель для лечения воспалительных заболеваний пародонта и слизистой оболочки полости рта, возникших на фоне психоэмоционального стресса
JPH10338633A (ja) 歯周疾患治療及び予防用組成物
RU2812828C1 (ru) Способ получения стоматологического геля противовоспалительного действия с пантогематогеном
KR100838270B1 (ko) 구강세정제 조성물 및 그의 제조방법
JPH0637379B2 (ja) 歯周疾患治療用外用剤
JPH09291018A (ja) 口腔用組成物
RU2521373C1 (ru) Способ местного лечения и профилактики основных стоматологических заболеваний у лиц пожилого и старческого возраста с применением жевательного фитосубстрата
CN110538084A (zh) 一种协同抗牙菌斑抑制口腔溃疡的复配物

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121109

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20121109

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140121

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140715